000640 - Dong-A Socio Holdings

Debt guarantee for a third party

Dong-A Socio Unit Signs ₩13.7 Billion Drug-Manufacturing Contract

Dong-A Socio Holdings subsidiary BTGen signed a ₩13.66 billion contract to manufacture pharmaceuticals for an unnamed global drug company. The value equals 13.2% of BTGen's 2025 separate-basis revenue. The customer will pay a ₩1.05 billion advance and make further payments as requested work is completed. The contract runs through June 30, 2027, but the end date may change by agreement.

Half-Year Report

Increase in short-term borrowings (subsidiary)

Record date set, shareholder register closed

Resolution to convene a general meeting of shareholders

Debt guarantee for a third party

Material event report (merger)

Preliminary Consolidated Results (Fair Disclosure)

Record date set, shareholder register closed

Material event report (merger)

Advance notice of results disclosure (notice)

Sustainability report (voluntary)

Dividend Declared

Record Date Set for a Dividend

Single Supply Contract Signed

Disposal of tangible assets (subsidiary)

Information security status (voluntary)

Sustainability report (voluntary)

Corporate governance report

Quarterly Report